Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,235,328
-$59,188 QoQ
Shares Held
51,301
+11.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,197
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CULLINAN ASSOCIATES INC holds $90,482,569 across 10 Drug Manufacturers - General names. PFE ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
177,028 | $44,959,801 | |
| 2 | ABBV |
AbbVie Inc.
|
68,800 | $17,312,832 | |
| 3 | AMGN |
Amgen Inc
|
24,288 | $8,795,170 | |
| 4 | LLY |
ELI LILLY & Co
|
6,866 | $8,235,287 | |
| 5 | MRK |
Merck & Co., Inc.
|
46,620 | $5,990,670 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
40,190 | $2,315,747 | |
| 7 | PFE |
Pfizer Inc
This page
|
51,301 | $1,235,328 | |
| 8 | NVS |
Novartis AG
|
4,700 | $736,584 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,235,328 | 51,301 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,294,516 | 46,101 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,376,994 | 55,301 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,242,265 | 88,001 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $1,854,384 | 76,501 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,638,332 | 64,654 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,678,128 | 63,254 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,878,321 | 64,904 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $7,333,110 | 262,084 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $7,720,105 | 278,202 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $5,608,810 | 194,818 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $9,513,487 | 286,810 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $11,613,254 | 316,610 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $13,285,459 | 325,624 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $12,885,271 | 251,469 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $11,000,957 | 251,393 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $12,166,958 | 232,061 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $9,612,084 | 185,669 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $5,542,019 | 93,853 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $3,521,228 | 81,870 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $9,820,153 | 250,770 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $10,106,249 | 278,947 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $10,269,032 | 278,974 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $9,578,727 | 261,001 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $8,403,941 | 257,001 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $8,329,879 | 255,205 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||